The product combines BPC-157, a synthetic pentadecapeptide analysed in models related to fibroblasts, angiogenesis and tissue response, and TB-500, a peptide linked to the active regions of thymosin beta-4, reported in the literature in the context of the actin cytoskeleton, cell migration and tissue remodelling
By inhibiting NNMT, 5-Amino-1MQ has been investigated for its potential to increase intracellular NAD+ levels and modulate lipid metabolism in preclinical settings
Every batch verified by Bioviridian HPLC-MS purity, MALDI identity, and endotoxin screening
These ranges are community-derived research references because no published clinical trial has tested the combination
You can buy BPC-157 from specialized peptide and research chemical suppliers, such as Direct Peptides